search

Canada Drug-Coated Balloons Market: Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)

$ PRICE - $ 3,000.00 – $ 8,900.00

Canada Drug-Coated Balloons Market: By Indication (PAD, CAD, others), By Drug Type (Paclitaxel, Sirolimus), By End-user (Hospitals
Ambulatory Care Settings, Freestanding Cath Labs) and Geography

Request Sample

Request Methodology

Request Sample

$ PRICE - $ 3,000.00 – $ 8,900.00

Clear selection

SKU: N/A Category: Healthcare

Description
Table Of Content
Company Profile

Report

Description

Canada Drug-Coated Balloons Market size was valued at USD million in 2021. It is expected to reach USD million by 2028, growing at a CAGR of 11.9% from 2022 to 2028. The market report provides a detailed overview of the market, which can be segmented by indication, drug type, and end-user. By indication, the Canadian drug-coated balloons market has been segmented into PAD, CAD, and others. The PAD segment is likely the most significant and fastest-growing segment regarding VARIOUS indications. The Canada drug-coated balloons market has been segmented by drug type into Paclitaxel and Sirolimus. The Paclitaxel segment accounted for the high revenue share in 2021. Based on end-user, the Canadian drug-coated balloons market is segmented into Hospitals, Ambulatory Care Settings, and Freestanding Cath Labs. The Hospitals segment is predicted to register the fastest growth rate during the forecast period, according to precision business insights.

Canada Drug-Coated Balloons Market

MARKET SUMMARY

11.9%

Study Period– 2022-2028
Base Year– 2021
CAGR– 11.9%

Canada Drug-Coated Balloons Market

The canada drug-coated balloons market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
The canada drug-coated balloons market report gives historical, current, and future market sizes (US$ Mn) based on drug type, indication, end user and geography.

Key Players

Biosensors International Group
Boston Scientific
B. Braun Melsungen
MedAlliance
BioMed

Canada Drug-Coated Balloons Market Drivers

A primary reason driving the drug-eluting balloons market is the increased incidence of cardiovascular, peripheral vascular, and neurovascular illnesses.

Canada Drug-Coated Balloons Market

Latin-America

North-America

Europe

Asia-Pacific

Middle East

Key

Features of the Report

The canada drug-coated balloons market report provides granular level information about the market size, regional market share, historic market (2017-2021) and forecast (2022-2028)
The canada drug-coated balloons market report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
The canada drug-coated balloons market report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
The canada drug-coated balloons market report tracks recent innovations, key developments, and start-up details that are actively working in the market
The canada drug-coated balloons market report provides a plethora of information about market entry strategies, regulatory framework, and reimbursement scenario

Canada Drug-Coated Balloons Market Segmentation

By Indication

PAD,
CAD,
others

drug type

Paclitaxel,
Sirolimus

By End User

Hospitals Ambulatory Care Settings,
Freestanding Cath Labs

Location

GEOGRAPHY

Frequently Asked Questions

The canada drug-coated balloons market is projected to expand at a CAGR of 11.9% during the forecast period.

The major players in the Canada drug-coated balloons market are Medtronic, Koninklijke Philips, BD, B. Braun Melsungen, Biosensors International Group, Boston Scientific, MedAlliance, and BioMed.

Report

Table Of Content

1. Canada Drug-Coated Balloons Market Introduction

1.1. Canada Drug-Coated Balloons Market – Taxonomy

1.2. Canada Drug-Coated Balloons Market –Definitions

1.2.1. By Indication

1.2.2. By Drug Type

1.2.3. By End User

2. Canada Drug-Coated Balloons Market Dynamics

2.1. Drivers

2.2. Restraints

2.3. Opportunities/Unmet Needs of the Market

2.4. Trends

2.5. Canada Drug-Coated Balloons Market Dynamic Factors – Impact Analysis

2.6. Canada Drug-Coated Balloons Market – Competition Landscape

3. Canada Drug-Coated Balloons Market Analysis,2017 – 2021 and Forecast, 2022 – 2028

3.1. Market Analysis,2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

3.2. Year-over-Year (Y-o-Y) Growth Analysis (%)

3.3. Market Opportunity Analysis

4. Canada Drug-Coated Balloons Market, By Indication, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

4.1. PAD

4.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

4.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

4.1.3. Market Opportunity Analysis

4.2. CAD

4.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

4.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

4.2.3. Market Opportunity Analysis

4.3. Others

4.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

4.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

4.3.3. Market Opportunity Analysis

5. Canada Drug-Coated Balloons Market Forecast, By Drug Type, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.1. Paclitaxel

5.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.1.3. Market Opportunity Analysis

5.2. Sirolimus

5.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

5.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

5.2.3. Market Opportunity Analysis

6. Canada Drug-Coated Balloons Market Forecast, By End User, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.1. Hospitals

6.1.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.1.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.1.3. Market Opportunity Analysis

6.2. Ambulatory Care Settings

6.2.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.2.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.2.3. Market Opportunity Analysis

6.3. Freestanding Cath Labs

6.3.1. Market Analysis, 2017 – 2021 and Forecast, 2022 – 2028 (Revenue, USD Mn)

6.3.2. Year-over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%)

6.3.3. Market Opportunity Analysis

7. Competition Landscape

7.1. Strategic Dashboard of Top Market Players

7.2. Company Profiles (Introduction, Financial Analysis, Drug Type& Service Offerings, Key Developments, Strategies, and SWOT Analysis)

7.2.1. Medtronic

7.2.2. Koninklijke Philips

7.2.3. BD

7.2.4. B. Braun Melsungen

7.2.5. Biosensors International Group

7.2.6. Boston Scientific

7.2.7. MedAlliance

7.2.8. BioMed

8. Research Methodology

9. Key Assumptions and Acronyms

Description
Reviews (0)

Description

Reviews

There are no reviews yet.

Be the first to review “Canada Drug-Coated Balloons Market: Estimation, Dynamics, Regional Share, Trends, Competitor Analysis (2017-2021) and Forecast (2022-2028)”